BSE - Delayed Quote INR
Brooks Laboratories Limited (BROOKS.BO)
140.00
-7.25
(-4.92%)
At close: 3:12:06 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
764,873
790,116
624,804
900,934
770,402
Cost of Revenue
554,243
610,620
612,210
757,989
552,402
Gross Profit
210,630
179,496
12,594
142,945
218,000
Operating Expense
189,544
165,057
348,097
359,971
284,002
Operating Income
21,086
14,439
-335,503
-217,026
-66,002
Net Non Operating Interest Income Expense
-9,678
-7,713
-20,911
-30,092
-29,290
Pretax Income
-181,148
-195,660
-383,700
-238,976
-89,853
Tax Provision
--
259
-73,240
-45,851
103,822
Net Income Common Stockholders
-181,148
-195,919
-208,919
-193,125
-193,755
Diluted NI Available to Com Stockholders
-181,148
-195,919
-208,919
-193,125
-193,755
Basic EPS
-6.99
-7.65
-12.57
-7.67
-7.03
Diluted EPS
-6.99
-7.65
-12.57
-7.67
-7.03
Basic Average Shares
26,108.72
25,616
24,703
25,184.30
24,944.83
Diluted Average Shares
26,108.72
25,616
24,703
25,184.30
24,944.83
Rent Expense Supplemental
--
90
90
3,045
180
Total Expenses
743,787
775,677
960,307
1,117,960
836,404
Net Income from Continuing & Discontinued Operation
-181,148
-195,919
-208,919
-193,125
-193,755
Normalized Income
-181,227
-195,998
-213,066.45
-196,792.16
-193,599.60
Interest Income
--
736
921
877
1,694
Interest Expense
9,212
7,247
19,537
28,312
30,984
Net Interest Income
-9,678
-7,713
-20,911
-30,092
-29,290
EBIT
-171,936
-188,413
-364,163
-210,664
-58,869
EBITDA
-155,234
-170,680
-293,895
-137,157
12,564
Reconciled Cost of Revenue
554,243
610,620
612,210
757,989
552,402
Reconciled Depreciation
16,702
17,733
70,268
73,507
71,433
Net Income from Continuing Operation Net Minority Interest
-181,148
-195,919
-208,919
-193,125
-193,755
Total Unusual Items Excluding Goodwill
79
79
5,126
4,538
-222
Total Unusual Items
79
79
5,126
4,538
-222
Normalized EBITDA
-155,313
-170,759
-299,021
-141,695
12,786
Tax Rate for Calcs
--
--
0
0
0
Tax Effect of Unusual Items
--
--
978.55
870.84
-66.60
3/31/2021 - 9/5/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade